How will Netflix-Warner merger affect consumer costs?
What fueled American Eagle’s sales surge?
Why did Trump back Matt Van Epps in Tennessee?
How is OpenAI responding to Google’s AI challenge?
What caused Thailand’s inflation to stay negative?
Why is Kalshi raising $1 billion now?
How are Amazon’s new AI chips competing with Nvidia?
Analysts See Big Upside For Newly Listed Molecular Diagnostic Firm BillionToOne After Standout IPO Rally
benzinga.com/analyst-stock-ratings/initiation/25/12/49142994/analysts-see-big-upside-for-newly-listed-molecular-diagnostic-firm-billiontoone
BillionToOne, Inc., (NASDAQ:BLLN) recently completed an upsized initial public offering, or IPO, of 5.23 million shares at $60 each, raising roughly $314 million.
The company, a commercial-stage molecular diagnostics company, offers specialized tests in prenatal genetics and…
This story appeared on benzinga.com, 2025-12-01 17:53:47.